Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission
暂无分享,去创建一个
R. Bouabdallah | D. Blaise | M. Mohty | D. Coso | N. Vey | A. Stoppa | C. Faucher | S. Fürst | H. Lavallade | J. Gastaut | J. El-Cheikh
[1] S. Yamasaki,et al. Mismatched unrelated cord blood transplantation in a patient with T-cell prolymphocytic leukemia , 2005, Leukemia.
[2] T. Takayama,et al. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement , 2003, International Journal of Clinical Oncology.
[3] D. Blaise,et al. Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. , 2003, Blood.
[4] B. Leber,et al. Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] D. Catovsky,et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. , 2001, Blood.
[6] H. Bittencourt,et al. Treatment of T‐prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation , 2001, European journal of haematology.
[7] R. Collins,et al. Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation , 1998, Bone Marrow Transplantation.
[8] D. Catovsky,et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. , 1991, Blood.